Venrock Adviser, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
-1,239,837
(-37.6%)
New positions
7
Sold out positions
6
Turnover %
77.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KORSANA BIOSCIENCES INC | 145,587 | NEW |
| DAMORA THERAPEUTICS INC | 76,685 | NEW |
| ADARX PHARMACEUTICALS INC | 32,418 | NEW |
| ACHV | 26,548 | 147.8% |
| ARVN | 15,103 | NEW |
| ENTXW | 14,859 | NEW |
| ANL | 14,458 | 39.1% |
| XFOR | 13,135 | 145.4% |
| SVRA | 10,139 | 11.2% |
| VRDN | 7,233 | 12.1% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|